NeoMatrix offers comprehensive and state of the art breast health solutions such as the HALO Breast Pap Test, a non-invasive breast cancer risk assessment device designed for use in the primary care setting as part of an annual well-woman visit... Learn more

 

 

 

Kassatkina will address the regulatory, cultural, and logistical differences between clinical research in the U.S. and Latin America. Other topics covered during the session include the key criteria to identifying a strong outsourcing partner with established relationships in Latin America, communications flow, and liability and requisite documentation ... Read more

 

Global Language Solutions is a SoCalBio Group Purchasing Program vendor. The company offers translation services to SocalBio members at significant discounts. Contact Ms. Kassatkina to learn more

 

With two potential approvals coming up in the next 120 days, the Irvine-based Spectrum Pharmaceuticals (Nasdaq: SPPI) appears to be a hidden gem... Read more

 

The patent application by the Woodland Hills-based company relates to new peptide candidates that may significantly expand the potential target patient population for the company's cancer stem cell vaccine product candidate, ICT-121 ... Read more

MiCardia (Irvine, Calif.) is developing Dynaplasty technology for the treatment of structural heart disease, focusing initially on mitral and tricuspid valve disorders and as a method of interrupting a major element in the onset and progression of Heart Failure ... Read more

 Allergan Receives FDA Approval for OZURDEX Biodegradable, Injectable Steroid Implant with Extended Drug Release for Retinal Disease

 

OZURDEX is a therapy administered via intravitreal injection delivering dexamethasone via Allergan's NOVADUR solid polymer delivery system. This biodegradable implant enables the extended release and effect of dexamethasone, and is placed in the vitreous cavity in the back of the eye treating the macular edema associated with RVO, thereby improving a patient's visual acuity.... Read more

 Watson Pharma to Buy Arrow Group for $1.75B

 

The privately held Arrow is one of the fastest growing generic drug companies, with $647 million in sales in 2008. Arrow owns the U.S. rights to the authorized generic version of Pfizer Inc.'s cholesterol drug Lipitor, which is the best-selling brand-name drug in the world. The generic is expected to reach the market in November 2011. This M&A deal is valued at about half of Watson's valuation ... Read more

 

 

Merger activity remains dry for Wall Street bankers and lawyers. But health care is one sector where there is at least a trickle of deal flow.
Watson Pharmaceuticals' $1.75 billion cash-and-stock purchase of closely held Arrow Group showed there are some deals to come by in the sector... Read more

SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio 

Southern California Biomedical Council (SoCalBio)